Vir Biotechnology Inc. (VIR)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 2,380,715 | $14,355,711 | 0.29% | |
| 2. | Balyasny Asset Management Dmitry Balyasny | 1,368,474 | $8,251,898 | 0.01% | |
| 3. | Hudson Bay Capital Management Sander Gerber | 1,325,000 | $7,989,750 | +46% | 0.03% |
| 4. | Millennium Management Israel Englander | 1,002,606 | $6,045,714 | -29% | 0% |
| 5. | GordonMD Global Investments Craig Gordon | 930,317 | $5,609,812 | 4.02% |
Hedge Fund Resource Center